TTR and cardiomyopathy: In cardiomyopathy, the deposition of transthyretin (TTR) increased the production of ROS, correlating with left ventricular systolic dysfunction, though likely indirectly from endoplasmic reticulum stress and calcium dyshomeostasis by non-fibrillar TTR species [89, 342–344].